IFM Investors Pty Ltd Boosts Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Key Points

• IFM Investors Pty Ltd increased its stake in GE HealthCare Technologies by 8.0% during the second quarter, owning 93,597 shares valued at approximately $6.93 million.
• A variety of institutional investors, including Tidal Investments LLC and Woodline Partners LP, also raised their holdings in GE HealthCare Technologies, indicating a growing interest in the stock among major investors.
• GE HealthCare Technologies reported better-than-expected earnings of $1.06 per share, surpassing analysts' estimates and demonstrating a 3.5% year-over-year revenue growth, totaling $5 billion for the quarter.

IFM Investors Pty Ltd grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 8.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 93,597 shares of the company's stock after acquiring an additional 6,899 shares during the period. IFM Investors Pty Ltd's holdings in GE HealthCare Technologies were worth $6,933,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of GEHC. N.E.W. Advisory Services LLC acquired a new position in shares of GE HealthCare Technologies in the first quarter worth $25,000. Bogart Wealth LLC grew its stake in shares of GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after purchasing an additional 247 shares in the last quarter. Stonebridge Financial Group LLC grew its stake in shares of GE HealthCare Technologies by 165.7% during the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after purchasing an additional 222 shares in the last quarter. Ameriflex Group Inc. acquired a new position in shares of GE HealthCare Technologies during the fourth quarter worth $31,000. Finally, Olde Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies during the first quarter worth $35,000. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC traded up $0.04 during trading hours on Tuesday, hitting $74.81. The company had a trading volume of 1,006,544 shares, compared to its average volume of 3,945,542. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The company has a market cap of $34.15 billion, a PE ratio of 15.34, a price-to-earnings-growth ratio of 2.86 and a beta of 1.13. The business has a 50 day moving average of $74.54 and a 200-day moving average of $73.02.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter in the prior year, the firm posted $1.00 earnings per share. GE HealthCare Technologies's revenue for the quarter was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, July 25th. GE HealthCare Technologies's dividend payout ratio is presently 2.87%.

Analysts Set New Price Targets

A number of brokerages recently commented on GEHC. Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a research note on Thursday. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Citigroup boosted their target price on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. Zacks Research upgraded shares of GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 28th. Finally, Wall Street Zen downgraded shares of GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research note on Saturday. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $88.40.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.